- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04906759
Meal Delivery and Exercise
December 15, 2023 updated by: Jessica Lee, The University of Texas Health Science Center, Houston
A Meal Delivery and Exercise Intervention to Increase Resilience in Homebound Older Adults
The purpose of this study is to evaluate the effects of a home-based exercise program administered through Meals on wheels (MOW) on gait speed and frailty status and to assess the association between novel serum biomarkers (70 kilodalton heat shock proteins (HSP70),Macrophage Inflammatory Proteins(MIP1b), soluble IL-6 receptor alpha-chain (sIL-6R)) and established but non-specific frailty biomarkers (Interleukin 6 (IL-6), C-reactive protein (CRP), Tumor necrosis factor (TNF-α)) in frail and prefrail homebound older adults before and after the exercise intervention.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jessica Lee, MD,MS
- Phone Number: 713-500-5457
- Email: Jessica.Lee@uth.tmc.edu
Study Contact Backup
- Name: Paola Robles Cordova
- Phone Number: (713) 500-7904
- Email: Paola.RoblesCordova@uth.tmc.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- The University of Texas Health Science Center at Houston
-
Contact:
- Jessica Lee, MD,MS
- Phone Number: 713-500-5457
- Email: Jessica.Lee@uth.tmc.edu
-
Contact:
- Paola Robles Cordova
- Phone Number: (713) 500-7904
- Email: Paola.RoblesCordova@uth.tmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- homebound (normally unable to leave the home unassisted)
- frail or prefrail by The Fried Frailty Phenotype (FFP)
- medically stable
Exclusion Criteria:
- robust by FFP
- have Mini-Cog score <3 and/or are unable to follow instructions
- have a pre-diagnosed terminal illness
- unable to ambulate
- unable to use their upper extremities, and/or are already participating in physician-prescribed physical therapy or occupational therapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Meals plus exercise
|
Participants will receive 12 weeks of a MOW delivery service that will include 2 meals per day during the weekdays with 4 shelf-stable meals at the end of the week.
The MOW driver will visit the participants in-person to ask a series of 5 questions about change in health status, joint/muscle injuries, new pain, falls, and poor appetite twice a week.
Participants will also will receive an exercise kit from the MOW driver with their first meal delivery which will contain 2 tennis balls, 2 1-pound hand weights, and one towel.
Every week, the driver will give the participants a handout containing 3 exercises from the NIA Go4Life Workout-to-Go book that are designed to help with strength/endurance, balance, and flexibility20.
The participants will be asked to do the 3 exercises every day, if possible, on their own.
Every 4 weeks during the 12-week study period and at 6 months follow up patients will have blood drawn for frailty and inflammatory biomarkers.
|
Experimental: Meals only
|
Participants will receive 12 weeks of a MOW delivery service that will include 2 meals per day during the weekdays with 4 shelf-stable meals at the end of the week.
The MOW driver will visit the participants in-person to ask a series of 5 questions about change in health status, joint/muscle injuries, new pain, falls, and poor appetite twice a week.
they will be asked to continue their usual level of activity.Every 4 weeks during the 12-week study period and at 6 months follow up patients will have blood drawn for frailty and inflammatory biomarkers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in gait speed
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
this is the time one takes to walk a specified distance on level surfaces over a short distance and is measured in meters/second
|
4 weeks,8 weeks,12 weeks from baseline
|
Change in total FFP score as assessed by the Fried Frailty Phenotype (FFP) screening test
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
Score from 0(not frail),1-2(pre frail) and 3-5(frail)
|
4 weeks,8 weeks,12 weeks from baseline
|
Change in measure of HSP70 (ng/mL) expression
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
Change in Measure of MIP-1β (pg/mL) expression
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
Change in Measure of sIL-6R (pg/mL) expression
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in overall frailty status as assessed by the Fried Frailty Phenotype (FFP) screening test
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
The FFP defines frailty as having 3 or more characteristics of unintentional weight loss, fatigue, decreased physical activity, weakness, and slowness.Those who have 1 or 2 characteristics are considered pre frail, while those who have no characteristics are robust.
|
4 weeks,8 weeks,12 weeks from baseline
|
Change in grip strength
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
Grip strength is a measure of muscular strength or the maximum force/tension generated by one's forearm muscles .This is measured by using a dynamometer which will be squeezed by the participant 3 times in each hand.The force is measured in kilograms.
|
4 weeks,8 weeks,12 weeks from baseline
|
Change in daily average steps from the activity tracker
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
Number of patients that required emergency room visits
Time Frame: 6 months post baseline visit
|
6 months post baseline visit
|
|
Number of patients that required hospitalization
Time Frame: 6 months post baseline visit
|
6 months post baseline visit
|
|
Change in activities of daily living as measured by the Katz Index of Independence in Activities of Daily Living
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
This consists of 6 questions and each is scored form 0(patient is very dependent)-6(patient is independent)
|
4 weeks,8 weeks,12 weeks from baseline
|
Change in instrumental activities of daily living as measured by the LAWTON - BRODY INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE (I.A.D.L.)
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
This consists of 8 questions and each has a summary score range from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias.
|
4 weeks,8 weeks,12 weeks from baseline
|
Change in loneliness as assessed by the UCLA Loneliness Scale (ULS)
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
This questionnaire consists of 20 questions and each is answered from 1(never)-4(always) for a total score ranging form 20-80
|
4 weeks,8 weeks,12 weeks from baseline
|
Social network as assessed by the LUBBEN SOCIAL NETWORK SCALE - 18 (LSNS-18)
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
LSNS-R total score is an equally weighted sum of twelve items.
Scores range from 0 to 90, a higher number indicating a better outcome
|
4 weeks,8 weeks,12 weeks from baseline
|
change in measure of IL-6 (pg/mL) expression
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
Change in measures of CRP (ng/mL) expression
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
Change in measures of TNF-α (pg/mL) expression
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
Change in measures of microbiome (fecal sample) expression
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
change in IL-6 (pg/mL) as measured by the frailty status
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
change in CRP (ng/mL) as measured by the frailty status
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
change in TNF-α (pg/mL) as measured by the frailty status
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
change in HSP70 (ng/mL) as measured by the frailty status
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
change in MIP-1β (pg/mL) as measured by the frailty status
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
change in sIL-6R (pg/mL) as measured by the frailty status
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
|
change in microbiome (fecal sample) as measured by the frailty status
Time Frame: 4 weeks,8 weeks,12 weeks from baseline
|
4 weeks,8 weeks,12 weeks from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jessica Lee, MD,MS, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 19, 2021
Primary Completion (Estimated)
February 28, 2026
Study Completion (Estimated)
February 28, 2026
Study Registration Dates
First Submitted
May 25, 2021
First Submitted That Met QC Criteria
May 25, 2021
First Posted (Actual)
May 28, 2021
Study Record Updates
Last Update Posted (Estimated)
December 21, 2023
Last Update Submitted That Met QC Criteria
December 15, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-MS-21-0125
- 1K23AG072042-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Xijing HospitalUnknownFrailty SyndromeChina
-
Region ZealandUniversity of Southern DenmarkActive, not recruitingFrailty SyndromeDenmark
-
Neurological Associates of West Los AngelesEnrolling by invitation
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompleted
Clinical Trials on Meals plus exercise
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)CompletedFrailtyUnited States
-
University of GlasgowCompleted
-
Universidad Autonoma de MadridUnknown
-
Istanbul Physical Medicine Rehabilitation Training...Completed
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)Completed
-
Bayside HealthThe Alfred; The Leukaemia Foundation of VictoriaUnknownRCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMTHematological MalignanciesAustralia
-
Universidad Complutense de MadridRecruiting
-
Universidad Complutense de MadridWithdrawnLateral EpicondylitisSpain
-
Texas Christian UniversityAbbottCompletedMalnutrition | ElderlyUnited States
-
Aristotle University Of ThessalonikiUnknownEnd Stage Renal Disease | Hypotension During Dialysis | Protein Malnutrition | Arterial SclerosisGreece